National Institutes of Health

Cleveland Clinic Innovations (CCI) is the commercialization arm of the Cleveland Clinic, established in 2000 and based in Cleveland, Ohio. It focuses on transforming the innovative inventions of Cleveland Clinic employees into medical products that benefit patients. CCI aims to create new business opportunities that extend the Cleveland Clinic's capabilities into the commercial market while fostering economic growth in Northeast Ohio and beyond. The organization promotes an inclusive entrepreneurial environment, encouraging participation from a diverse range of stakeholders, including physicians, nurses, researchers, and administrators. CCI employs a comprehensive approach that features deal teams, domain experts, investment funds, and incubation facilities, all designed to support the development and commercialization of new medical technologies. Through these efforts, CCI facilitates the creation of companies and the deployment of advancements in healthcare.

Case Western Reserve University, located in Cleveland's University Circle, is an independent research institution established in 1843. It encompasses various schools and colleges, including the School of Medicine, School of Law, Case School of Engineering, College of Arts and Sciences, Frances Payne Bolton School of Nursing, Mandel School of Applied Social Sciences, School of Dental Medicine, and Weatherhead School of Management. The university is known for its excellence in medical education and biomedical research, with the School of Medicine recognized for its contributions to medical discoveries and training future physicians. The School of Law offers nationally ranked programs in international law, health law, and intellectual property law, integrating leadership courses and practical experiences into its curriculum. Case Western Reserve University is a member of the Association of American Universities and maintains full accreditation from the Higher Learning Commission, reflecting its commitment to educational quality and research excellence.

Cleveland Clinic Innovations (CCI) is the commercialization arm of the Cleveland Clinic, established in 2000 and based in Cleveland, Ohio. It focuses on transforming the innovative inventions of Cleveland Clinic employees into medical products that benefit patients. CCI aims to create new business opportunities that extend the Cleveland Clinic's capabilities into the commercial market while fostering economic growth in Northeast Ohio and beyond. The organization promotes an inclusive entrepreneurial environment, encouraging participation from a diverse range of stakeholders, including physicians, nurses, researchers, and administrators. CCI employs a comprehensive approach that features deal teams, domain experts, investment funds, and incubation facilities, all designed to support the development and commercialization of new medical technologies. Through these efforts, CCI facilitates the creation of companies and the deployment of advancements in healthcare.

Cytonus Therapeutics, Inc. is a biotechnology company founded in 2018 and based in Columbus, Ohio. The company focuses on developing immune-oncology and gene therapies aimed at treating devastating and rare diseases. Cytonus combines artificial intelligence-driven drug discovery with a unique delivery system known as Cargocyte, which utilizes synthetic biology for precision treatment. The company's mission centers on addressing immune-related disorders through innovative approaches that enable targeted delivery and in vivo production of first-in-class therapeutics.

Cytonus Therapeutics, Inc. is a biotechnology company founded in 2018 and based in Columbus, Ohio. The company focuses on developing immune-oncology and gene therapies aimed at treating devastating and rare diseases. Cytonus combines artificial intelligence-driven drug discovery with a unique delivery system known as Cargocyte, which utilizes synthetic biology for precision treatment. The company's mission centers on addressing immune-related disorders through innovative approaches that enable targeted delivery and in vivo production of first-in-class therapeutics.

Cytonus Therapeutics, Inc. is a biotechnology company founded in 2018 and based in Columbus, Ohio. The company focuses on developing immune-oncology and gene therapies aimed at treating devastating and rare diseases. Cytonus combines artificial intelligence-driven drug discovery with a unique delivery system known as Cargocyte, which utilizes synthetic biology for precision treatment. The company's mission centers on addressing immune-related disorders through innovative approaches that enable targeted delivery and in vivo production of first-in-class therapeutics.

Cytonus Therapeutics, Inc. is a biotechnology company founded in 2018 and based in Columbus, Ohio. The company focuses on developing immune-oncology and gene therapies aimed at treating devastating and rare diseases. Cytonus combines artificial intelligence-driven drug discovery with a unique delivery system known as Cargocyte, which utilizes synthetic biology for precision treatment. The company's mission centers on addressing immune-related disorders through innovative approaches that enable targeted delivery and in vivo production of first-in-class therapeutics.

Cleveland Clinic Innovations (CCI) is the commercialization arm of the Cleveland Clinic, established in 2000 and based in Cleveland, Ohio. It focuses on transforming the innovative inventions of Cleveland Clinic employees into medical products that benefit patients. CCI aims to create new business opportunities that extend the Cleveland Clinic's capabilities into the commercial market while fostering economic growth in Northeast Ohio and beyond. The organization promotes an inclusive entrepreneurial environment, encouraging participation from a diverse range of stakeholders, including physicians, nurses, researchers, and administrators. CCI employs a comprehensive approach that features deal teams, domain experts, investment funds, and incubation facilities, all designed to support the development and commercialization of new medical technologies. Through these efforts, CCI facilitates the creation of companies and the deployment of advancements in healthcare.

Cytonus Therapeutics, Inc. is a biotechnology company founded in 2018 and based in Columbus, Ohio. The company focuses on developing immune-oncology and gene therapies aimed at treating devastating and rare diseases. Cytonus combines artificial intelligence-driven drug discovery with a unique delivery system known as Cargocyte, which utilizes synthetic biology for precision treatment. The company's mission centers on addressing immune-related disorders through innovative approaches that enable targeted delivery and in vivo production of first-in-class therapeutics.

Cleveland Clinic Innovations (CCI) is the commercialization arm of the Cleveland Clinic, established in 2000 and based in Cleveland, Ohio. It focuses on transforming the innovative inventions of Cleveland Clinic employees into medical products that benefit patients. CCI aims to create new business opportunities that extend the Cleveland Clinic's capabilities into the commercial market while fostering economic growth in Northeast Ohio and beyond. The organization promotes an inclusive entrepreneurial environment, encouraging participation from a diverse range of stakeholders, including physicians, nurses, researchers, and administrators. CCI employs a comprehensive approach that features deal teams, domain experts, investment funds, and incubation facilities, all designed to support the development and commercialization of new medical technologies. Through these efforts, CCI facilitates the creation of companies and the deployment of advancements in healthcare.

Kent State University, located in Kent, Ohio, is a prominent public doctoral university established in 1910, recognized for its high research activity. As the highest-ranking public university in Northern Ohio, it offers a diverse array of academic programs, including undergraduate majors in fields such as Biomedical Sciences, Communication Studies, Psychology, and Visual Communication and Design. Students have access to over 300 academic programs across Kent State's eight campuses and can participate in more than 200 student organizations, fostering a vibrant campus life. The university provides various financial aid options, including need-based awards and graduate assistantships, to support students in their educational pursuits. Admissions for freshmen require a minimum GPA and standardized test scores, though alternative pathways exist for those who do not meet these criteria. Kent State University plays a vital role in the educational landscape of Ohio, contributing to the development of its students through comprehensive academic and extracurricular offerings.

Cleveland Clinic Innovations (CCI) is the commercialization arm of the Cleveland Clinic, established in 2000 and based in Cleveland, Ohio. It focuses on transforming the innovative inventions of Cleveland Clinic employees into medical products that benefit patients. CCI aims to create new business opportunities that extend the Cleveland Clinic's capabilities into the commercial market while fostering economic growth in Northeast Ohio and beyond. The organization promotes an inclusive entrepreneurial environment, encouraging participation from a diverse range of stakeholders, including physicians, nurses, researchers, and administrators. CCI employs a comprehensive approach that features deal teams, domain experts, investment funds, and incubation facilities, all designed to support the development and commercialization of new medical technologies. Through these efforts, CCI facilitates the creation of companies and the deployment of advancements in healthcare.

Nervive is a stock-based Delaware C-corp that develops a new treatment for brain ischemia. Its primary product, VitalFlow Stimulator, is non-invasive platform technology that treats conditions of brain ischemia such as cerebral artery vasospasm, ischemic stroke, and traumatic brain injury. Founded in 2013, Nervive is headquartered in Akron, Ohio.

Cleveland Clinic Innovations (CCI) is the commercialization arm of the Cleveland Clinic, established in 2000 and based in Cleveland, Ohio. It focuses on transforming the innovative inventions of Cleveland Clinic employees into medical products that benefit patients. CCI aims to create new business opportunities that extend the Cleveland Clinic's capabilities into the commercial market while fostering economic growth in Northeast Ohio and beyond. The organization promotes an inclusive entrepreneurial environment, encouraging participation from a diverse range of stakeholders, including physicians, nurses, researchers, and administrators. CCI employs a comprehensive approach that features deal teams, domain experts, investment funds, and incubation facilities, all designed to support the development and commercialization of new medical technologies. Through these efforts, CCI facilitates the creation of companies and the deployment of advancements in healthcare.

Cleveland Clinic Innovations (CCI) is the commercialization arm of the Cleveland Clinic, established in 2000 and based in Cleveland, Ohio. It focuses on transforming the innovative inventions of Cleveland Clinic employees into medical products that benefit patients. CCI aims to create new business opportunities that extend the Cleveland Clinic's capabilities into the commercial market while fostering economic growth in Northeast Ohio and beyond. The organization promotes an inclusive entrepreneurial environment, encouraging participation from a diverse range of stakeholders, including physicians, nurses, researchers, and administrators. CCI employs a comprehensive approach that features deal teams, domain experts, investment funds, and incubation facilities, all designed to support the development and commercialization of new medical technologies. Through these efforts, CCI facilitates the creation of companies and the deployment of advancements in healthcare.